Power Law company profile

Loxo Oncology

Biotech & Life Sciences · York, United Kingdom · Founded 2013 · IPO 2014 Unicorn

Loxo Oncology - Targeting Cancer with Strong Chemistry

Valuation

$5–10B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

3 investors on Loxo Oncology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Aisling Capital

OrbiMed

Series B+ 1 investor entered at this stage

NEA

Global footprint

Where Loxo Oncology has talent and traffic

AI talent share

0.4% of workforce is AI talent
(1 of 257 staff)

Core AI10.39%

Other AI00%

Non-AI workforce25699.61%

Workforce by country

4 countries with
team presence

🇺🇸 United States98.5%

🇧🇩 Bangladesh0.5%

🇳🇱 Netherlands0.5%

🇺🇦 Ukraine0.5%

4 countries shown

Web traffic by country

50 monthly visits
across markets

🇺🇸 United States3400%

🇮🇳 India400%

Top 2 markets shown

Patent intelligence

$130M patent portfolio · 45 active families

Estimated portfolio value

$130M

1.6% of valuation · 3.1× smaller than top peer Seagen ($403M)

45 active patent families

Where Loxo Oncology innovates CarcinosisPyrazoleDiseaseMolecular biologyTyrosine

Where Loxo Oncology concentrates vs peers

Each axis is a top-10 topic across Loxo Oncology and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Loxo Oncology

An AI-synthesized read of the highest-engagement posts about Loxo Oncology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Loxo Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles